483
Labcorp Clinical Research Unit, Inc.Labcorp Clinical Research Unit, Inc. – FDA 483, Oct 7, 2022
Record Details
Covance Cru Inc in Madison, WI, was cited for failing to conduct investigations in accordance with the signed statement of investigator and investigational plan during a bioequivalence study. Specifically, the firm did not report an identified autoinjector device defect, a black particle, to the sponsor as required by the study protocol and sponsor agreement. This indicates a deviation from established procedures for handling product complaints.
View Company Profile
ID · 60aaa680-02b0-4c34-8a1b-8c895ef49045
Other documents for Labcorp Clinical Research Unit, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.